BACKGROUND AND PURPOSEAdenophostin A (AdA) is a potent agonist of inositol 1,4,5-trisphosphate receptors (IP3R). AdA shares with IP3 the essential features of all IP3R agonists, namely structures equivalent to the 4,5-bisphosphate and 6-hydroxyl of IP3, but the basis of its increased affinity is unclear. Hitherto, the 2′-phosphate of AdA has been thought to provide a supra-optimal mimic of the 1-phosphate of IP3.EXPERIMENTAL APPROACHWe examined the structural determinants of AdA binding to type 1 IP3R (IP3R1). Chemical synthesis and mutational analysis of IP3R1 were combined with 3H-IP3 binding to full-length IP3R1 and its N-terminal fragments, and Ca2+ release assays from recombinant IP3R1 expressed in DT40 cells.KEY RESULTSAdenophostin A is at least 12-fold more potent than IP3 in functional assays, and the IP3-binding core (IBC, residues 224–604 of IP3R1) is sufficient for this high-affinity binding of AdA. Removal of the 2′-phosphate from AdA (to give 2′-dephospho-AdA) had significantly lesser effects on its affinity for the IBC than did removal of the 1-phosphate from IP3 (to give inositol 4,5-bisphosphate). Mutation of the only residue (R568) that interacts directly with the 1-phosphate of IP3 decreased similarly (by ∼30-fold) the affinity for IP3 and AdA, but mutating R504, which has been proposed to form a cation-π interaction with the adenine of AdA, more profoundly reduced the affinity of IP3R for AdA (353-fold) than for IP3 (13-fold).CONCLUSIONS AND IMPLICATIONSThe 2′-phosphate of AdA is not a major determinant of its high affinity. R504 in the receptor, most likely via a cation-π interaction, contributes specifically to AdA binding.